TWST News and Press, Twist Bioscience Corporation From 03/28/24

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human Pangenome Spike-in for the Twist Exome 2.0 panel developed to enable researchers to detec...

2024-03-13 14:01:40 ET More on Qiagen, Bio-Techne, etc. Qiagen N.V. 2023 Q4 - Results - Earnings Call Presentation Qiagen N.V. (QGEN) Q4 2023 Earnings Call Transcript Bio-Techne Corporation (TECH) Q2 2024 Earnings Call Transcript Qiagen upgraded at Morgan Sta...

Precision Dx Products are CE-marked and compliant with EU IVDR 2017/746 regulations Precision Dx Products include Twist Precision Prep and Enrichment Dx Kit, Twist Precision Exome Dx Panel and Twist Precision Exome Dx Kit Twist Bioscience Corporation (NASDAQ: TWST), a company enab...

2024-02-24 03:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-13 13:59:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips You can’t say Cathie Wood is afraid to make big bets. The investing guru is more than willing to lay it all on the line for stocks she believes in. Of the top Cathie Wood stocks picked u...

2024-02-12 03:08:36 ET Summary Twist Bioscience specializes in synthetic biology and DNA applications, focusing on synthetic DNA, DNA products, and Next-Generation Sequencing tools. The company's revenue-generating segments, particularly DNA synthesis, show high growth and cost re...

2024-02-07 09:22:26 ET Summary Twist Bioscience reported strong results in the first quarter of FY2024, despite a tepid demand environment. Growth was somewhat exaggerated by lumpy NGS revenue, but overall the business is progressing well, particularly from a profitability perspec...

Twist for Element, Exome 2.0 plus Comprehensive Exome Spike-in Workflow expected to be available soon Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Element Biosc...

High accuracy and detection to identify tumor variants from degraded and low input samples as well as samples with limited DNA abundance Library preparation kit adds to Twist’s portfolio of tools to enable liquid biopsy applications Twist Bioscience Corporation (NASDAQ: TWS...

Early access of novel technology that enables preparation of thousands of samples at low cost through self-normalization, enhanced multiplexing, and streamlined workflow Innovative solution positioned to drive NGS adoption in AgBio Twist Flex Prep UHT Kit and additional NGS tools to be hi...